The Role Of Upfront Surgery in the Management of Ileal Crohn’s Disease
DOI:
https://doi.org/10.58931/cibdt.2024.2228Abstract
Crohn's disease (CD) is a chronic inflammatory disorder characterized by transmural inflammation that can affect any part of the gastrointestinal tract. Among the various phenotypes of CD, involvement of the terminal ileum, known as ileal CD, poses unique challenges in management due to its potential for complications such as strictures, fistulas, and abscesses. While medical therapy remains a cornerstone in the management of CD, the role of surgery, particularly upfront surgical intervention (early resection), has garnered increasing attention in recent years.
The decision to pursue surgical intervention at the outset of disease management, rather than relying solely on medical therapy, is a subject of ongoing debate in the field. Upfront surgery (prior to advanced medical therapies) may offer benefits such as rapid resolution of symptoms, avoidance of long-term immunosuppressive therapy and prevention of disease progression. However, concerns regarding the postoperative morbidity and potential for recurrence associated with surgical intervention warrant careful consideration.
References
Roda G, Chien Ng S, et al. Crohn’s disease. Nat Rev Dis Prim. 2020 Dec 1;6(1). DOI: https://doi.org/10.1038/s41572-020-0156-2
Yamamoto T, Lightner AL, Spinelli A, et al. Perioperative management of ileocecal Crohn’s disease in the current era. Expert Rev Gastroenterol Hepatol. 2020 Sep 1 [cited 2024 May 27];14(9):843-55. DOI: https://doi.org/10.1080/17474124.2020.1802245
Avellaneda N, Kotze PG. Author’s reply: “Early surgery for Crohn’s disease-An appeal for a reassessment of biologics.” Dig Liver Dis. 2023 Dec 1;55(12):1777-8. DOI: https://doi.org/10.1016/j.dld.2023.09.005
Agrawal M, Ebert AC, Poulsen G, et al. Early ileocecal resection for Crohn's disease is associated with improved long-term outcomes compared with anti-tumor necrosis factor therapy: a population-based cohort study.. Gastroenterol. 2023 Oct 1;165(4):976-985.e3. DOI: https://doi.org/10.1053/j.gastro.2023.05.051
Ponsioen CY, de Groof EJ, Eshuis EJ, A, et al. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. Lancet Gastroenterol Hepatol. 2017 Nov 1;2(11):785-92.
Stevens TW, Haasnoot ML, D’Haens GR, et al. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: retrospective long-term follow-up of the LIR!C trial. Lancet Gastroenterol Hepatol. 2020 Oct 1;5(10):900-7.
Vieujean S, Kotze PG, Netter P, et al. Stemming the tide with ileocecal Crohn’s disease: when is pharmacotherapy enough? Expert Opin Pharmacother. 2023;24(14):1595-607. DOI: https://doi.org/10.1080/14656566.2023.2232726
Colombel JF, Panaccione R, Bossuyt P, et al. Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2017 Dec 23;390(10114):2779-89. DOI: https://doi.org/10.1016/S0140-6736(17)32641-7
Kotze PG, Magro DO, Martinez CAR, et al. Long Time from Diagnosis to Surgery May Increase Postoperative Complication Rates in Elective CD Intestinal Resections: An Observational Study. Gastroenterol Res Pract. 2018 Apr 23;2018:4703281. DOI: https://doi.org/10.1155/2018/4703281
Avellaneda N, Coy CSR, Fillmann HS, et al. Earlier surgery is associated to reduced postoperative morbidity in ileocaecal Crohn’s disease: Results from SURGICROHN - LATAM study. Dig Liver Dis. 2023 May 1;55(5):589-94. DOI: https://doi.org/10.1016/j.dld.2022.09.011
Maruyama BY, Ma C, Panaccione R, Kotze PG. Early Laparoscopic ileal resection for localized ileocecal Crohn's disease: hard sell or a revolutionary new norm? Inflamm Intest Dis. 2021 Jan 19;7(1):13-20. DOI: https://doi.org/10.1159/000515959
Avellaneda N, Maroli A, Tottrup A, et al. Short and long-term outcomes of surgery for inflammatory (uncomplicated) ileocecal Crohn’s disease: Multicentric retrospective analysis of 211 patients. Dig Liver Dis. 2024 May 1;56(5):730-6. DOI: https://doi.org/10.1016/j.dld.2023.10.017
Maggiori L, Panis Y. Laparoscopy in Crohn’s disease. Best Pract Res Clin Gastroenterol. 2014;28(1):183-94. DOI: https://doi.org/10.1016/j.bpg.2013.11.004
Bhattacharya P, Hussain MI, Zaman S, et al. Single-incision versus multi-port laparoscopic ileocolic resections for Crohn’s disease: Systematic review and meta-analysis. J Minim Access Surg. 2023 Oct 1 [;19(4):518-28. DOI: https://doi.org/10.4103/jmas.jmas_6_23
Gardenbroek TJ, Verlaan T, Tanis PJ, et al. Single-port versus multiport laparoscopic ileocecal resection for Crohn’s disease. J Crohns Colitis. 2013 Nov 1;7(10)e443-8. DOI: https://doi.org/10.1016/j.crohns.2013.02.015
Zaman S, Mohamedahmed AYY, Abdelrahman W, et al. Minimally invasive surgery for Inflammatory Bowel Disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques. J Crohns Colitis. 2024 Mar 11; epub ahead of print. DOI: https://doi.org/10.1093/ecco-jcc/jjae065
Crohn BB, Ginzburg L, Oppenheimer GD. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. JAMA. 1984 Jan 6;251(1):73-9. DOI: https://doi.org/10.1001/jama.251.1.73
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Canadian IBD Today
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
